Moderna to launch trials of new booster vaccine that targets South African Covid variant

The Boston-based biotech has already shipped the raw materials to the US National Institutes of Health, which helped the firm study its first jab, to start human trials.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news